News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
A surge of demand in biologics contract testing and biosimilar characterization has caused BioOutsource to double its capacity with the opening of a new facility in Glasgow, Scotland.
Thermo Fisher has added a dry powder media plant in the UK and a site in Dubai as part of its Life Sciences growth strategy.
Remicade biosimilars have had no meaningful impact on AbbVie’s parallel TNF inhibitor Humira, management says, despite international Q2 sales of the mAb being down 14% year-on-year.